RxDoctor Payments Data

Luis Cava Prado, MD

Neurocritical Care · Aurora, CONPI 1801018221

Payments from drug & device makers

$207,351in general payments, 2019–2025

Across 41 payments — averaging $5057.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$103K
  • C. R. Bard, Inc. & Subsidiaries$70K
  • Shionogi Inc$34K
  • Zimmer Biomet$140
  • Medtronic$136
  • AstraZeneca$120
  • plus $29 from 1 others

What the payments were for

  • Food & beverage$435100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Integra Lifesciences Corporation23$102,907
C. R. Bard, Inc. & Subsidiaries6$69,632
Shionogi Inc5$34,389
Zimmer Biomet3$140
Medtronic2$136
AstraZeneca1$120
Medivance, Inc.1$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurocritical care providers in Coloradoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$80,140
Medicare patients
97
Services billed
465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurocritical care in Aurora

Where these figures come from

Is this you, or does something look wrong? →